Welcome to the e-CCO Library!

P035: Lamina propria CD4+LAP+ Foxp3- regulatory cells are involved in limiting the disease extension in Ulcerative Colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Butera1, A. Amendola1, M. Sanchez2, S. Piroli3, A. Pronio3, D. De Nitto4, R. Pica4, M. Boirivant*1

Created: Friday, 22 February 2019, 9:49 AM
P035: Pharmacological inhibition of the canonical WNT signalling pathway represents a potential novel therapy for fibrosis in Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Lewis*1, A. Nijhuis1, G. Berti1, C. L. Bishop2, R. Feakins3, J. O. Lindsay4, A. Silver1

Created: Friday, 22 February 2019, 9:41 AM
P035: Potential biomarkers for diagnosis through proteomics, in patients with Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Muñoz-Villafranca, C.(1);Aresti Goiriena, U.(2);Ispizua, N.(1);Irigoyen Muñoz, M.(3);Rivera Garcia, N.A.(2);Ortiz de Zárate, J.(1);Arreba Gonzalez , P.(1);Calderón García, Á.J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P035: Serum markers predict outcome to ustekinumab in patients with refractory Crohn’s disease and provide insides in the mechanism of action
Year: 2018
Source: ECCO '18 Vienna
Authors:

B. Verstockt1,2*, S. Vermeire1,2, S. Verstockt3, B. Creyns4, N. Ardeshir Davani2, C. Breynaert4, G. Van Assche1,2, G. Van Assche1,2, M. Ferrante1,2

Created: Thursday, 21 February 2019, 9:14 AM
P035: TNF-driven pathways are increased at baseline in Crohn's disease patients not responding to infliximab
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Verstockt B.*1,2, Arijs I.1,3,4, de Bruyn M.1,5, Verstockt S.6, Van Assche G.1,7, Breynaert C.8, Vermeire S.1,7, Ferrante M.1,7

Created: Wednesday, 20 February 2019, 10:36 AM
P036 A novel p53-mediated mouse model of inflammatory bowel disease-associated colorectal cancer
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A.M. Churchhouse1, C.V. Billard1, M.J. Arends2, K.B. Myant1

Created: Thursday, 30 January 2020, 10:12 AM
P0360: Bowel Ultrasonography and Computed Tomography tell the same story using different languages in analizing Crohnˈs disease lesions
Year: 2025
Source: ECCO'25
Authors: Lesx7x7x7 A.(1)*;Sarbux7x7x7 A.M.(2);Dumitrux7x7x7 R.(2);Saizux7x7x7 R.(3);Gheorghex7x7x7 L.(1);Gheorghex7x7x7 C.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0361: Clinical outcomes of acute severe colitis in Latin American: a case series.
Year: 2025
Source: ECCO'25
Authors: Burmannx7x7x7 B.P.(1);Barrosx7x7x7 L.L.(1)*;Romerox7x7x7 A.E.P.(1);Salgadox7x7x7 J.G.D.(1);Pradox7x7x7 R.D.C.P.(1);Mattosx7x7x7 P.S.L.D.(1);Azevedox7x7x7 M.F.C.D.(1);Carlosx7x7x7 A.D.S.(1);Damiãox7x7x7 A.O.M.C.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0362: Bowel urgency in inflammatory bowel disease: The URGENT index
Year: 2025
Source: ECCO'25
Authors: Caronx7x7x7 B.(1)*;Bouhnikx7x7x7 Y.(2);Stefanescux7x7x7 C.(2);Tretonx7x7x7 X.(2);Buissonx7x7x7 A.(3);Bourreillex7x7x7 A.(4);Fumeryx7x7x7 M.(5);Nachuryx7x7x7 M.(6);Roblinx7x7x7 X.(7);Nanceyx7x7x7 S.(8);Vicautx7x7x7 E.(9);Peyrin-Birouletx7x7x7 L.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0363: Explore the application value of serum GOLM1 in the diagnosis of Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Zhaox7x7x7 Y.(1)*;Panx7x7x7 L.(1);Pux7x7x7 T.(1);Wenx7x7x7 H.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0364: Establishment and validation of a central reader pool for magnetic resonance enterography (MRE) for use in Crohn’s disease clinical trials
Year: 2025
Source: ECCO'25
Authors: Pillayx7x7x7 L.(1)*;Paverdx7x7x7 H.(2);Noorx7x7x7 N.(1);Hickmanx7x7x7 K.(2);De Paepex7x7x7 K.(3);Godfreyx7x7x7 E.M.(2);Khwajax7x7x7 S.(2);Upponix7x7x7 S.(2);Kennedyx7x7x7 N.A.(4);Parkesx7x7x7 M.(1);Rainex7x7x7 T.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0365: The evolution of Geldof fistula class in patients with Crohn's disease perianal fistula
Year: 2025
Source: ECCO'25
Authors: Ibrahimx7x7x7 F.A.E.(1)*;Sebastianx7x7x7 S.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0366: Endoscopic remission in Crohn’s diseasex7x7x7 the CREDO trial: Inter-reader variation study of the detection of endoscopic lesions assumed consensually to be related to remission.
Year: 2025
Source: ECCO'25
Authors: BossuytMD PhDx7x7x7 P.(1)*;Maryx7x7x7 J.Y.(2);Louisx7x7x7 E.(3);Baertx7x7x7 F.(4);Caillox7x7x7 L.(5);de Surayx7x7x7 N.(6);Dewintx7x7x7 P.(7);Ferrantex7x7x7 M.(8);Filippix7x7x7 J.(9);Lahariex7x7x7 D.(10);Reenaersx7x7x7 C.(3);SImonx7x7x7 M.(11);Stefanescux7x7x7 C.(12);Trangx7x7x7 C.(13);Vuittonx7x7x7 L.(14);Vermeirex7x7x7 S.(8);Bouhnikx7x7x7 Y.(12);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0367: A Clustering approach to discriminate slow and rapid biologics switchers in difficult-to-treat Crohn’s Disease patients.
Year: 2025
Source: ECCO'25
Authors: Vuckovicx7x7x7 C.(1)*;Cremerx7x7x7 A.(1);Minsartx7x7x7 C.(1);Amininejadx7x7x7 L.(1);Bottieaux7x7x7 J.(2);Franchimontx7x7x7 D.(1);Liefferinckxx7x7x7 C.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0368: Novel endoluminal parameters to predict primary loss of response in patients with Crohn’s disease: a national survey and multi-centre study.
Year: 2025
Source: ECCO'25
Authors: Shenx7x7x7 J.(1);Fengx7x7x7 Q.(2);Yaox7x7x7 R.(1)*;Caix7x7x7 C.(1);Liangx7x7x7 J.(3);Tianx7x7x7 F.(4);Caox7x7x7 X.(5);Lix7x7x7 Y.(6);Gux7x7x7 Y.(7);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0369: The use of exhaled volatile organic compounds for the non-invasive assessment of endoscopic inflammation in patients with ileal pouch anal anastomosis (IPAA)
Year: 2025
Source: ECCO'25
Authors: Qazix7x7x7 T.(1)*;Cohenx7x7x7 B.(2);Max7x7x7 J.(3);Yangx7x7x7 Q.(4);Grovex7x7x7 D.(3);Regueirox7x7x7 M.(5);Dweikx7x7x7 R.(6);Riederx7x7x7 F.(7);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P036: Analysis of intestinal tissue from newly diagnosed patients with inflammatory bowel disease reveals distinct proteomic profiles
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Baldan-Martin, M.(1)*;Lloro, I.(2);Azkargorta, M.(2);Ramírez, C.(1);Soleto Fernández, I.(1);Orejudo, M.(1);García, S.(1);Mercado, J.(1);Gordillo, C.H.(3);Riestra, S.(4);Rivero, M.(5);Gutiérrez, A.(6);Rodríguez-Lago, I.(7);Fernández-Salazar, L.(8);Ceballos, D.(9);Benítez, J.M.(10);Aguas, M.(11);Bastón-Rey, I.(12);Bermejo, F.(13);Casanova, M.J.(1);Lorente, R.(14);Ber, Y.(15);Royo, V.(16);Esteve, M.(17);Elortza, F.(2);Gisbert, J.P.(1);Chaparro, M.(1);
Created: Friday, 14 July 2023, 10:48 AM
P036: Colon targeted delivery of tofacitinib inhibits oxazolone-induced colitis in mice, despite low systemic exposure
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

F. Shen*, P. Brassil, S. Hegde, D. Beattie

Created: Friday, 22 February 2019, 9:49 AM
P036: Expression of CD69 on peripheral lymphocytes predicts treatment response in Acute Severe ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. C. Choy*1,2,3, J. Yu2, M. Congiu2, P. Pelpola2, J. Nigro2, R. Burder1, K. Boyd1, M. McGuckin4, A. J. Corbett5, L. Kjer-Nielsen5, J. McCluskey5, K. Visvanathan2, P. De Cruz1,3

Created: Friday, 22 February 2019, 9:41 AM
P036: Faecalibacterium prausnitzii produces butyrate to maintain Th17/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Zhou1*, M. Zhang1,2,3, Y. Wang1, T. Yu1,4, X. Chen1, D. Tang1, L. Xu1, Y. Yin1, Y. Pan5, Q. Zhou6, Y. Zhou1, C. Yu1,2

Created: Thursday, 21 February 2019, 9:14 AM